Literature DB >> 20864635

EPCAM germ line deletions as causes of Lynch syndrome in Spanish patients.

Carla Guarinos1, Adela Castillejo, Víctor-Manuel Barberá, Lucía Pérez-Carbonell, Ana-Beatriz Sánchez-Heras, Angel Segura, Carmen Guillén-Ponce, Ana Martínez-Cantó, María-Isabel Castillejo, Cecilia-Magdalena Egoavil, Rodrigo Jover, Artemio Payá, Cristina Alenda, José-Luís Soto.   

Abstract

The standard genetic test for Lynch syndrome (LS) frequently reveals an absence of pathogenic mutations in DNA mismatch repair genes known to be associated with LS. It was recently shown that germ line deletions in the last exons of EPCAM are involved in the etiology of LS. The aim of this study was to evaluate the prevalence of EPCAM deletions in a Spanish population and the clinical implications of deletion. Probands from 501 families suspected of having LS were enrolled in the study. Twenty-five cases with MSH2 loss were identified: 10 had mutations of MSH2, five had mutations of MSH6, and 10 did not show MSH2/MSH6 mutations. These 25 cases were analyzed for EPCAM deletions using multiplex ligation-dependent probe amplification, and deletions were mapped using long-range PCR analysis. One subject with no MSH2/MSH6 mutations had a large deletion in the EPCAM locus that extended for 8.7 kb and included exons 8 and 9. The tumor exhibited MSH2 promoter hypermethylation. EPCAM deletion analysis followed by MSH2 methylation testing of the tumor is a fast low-cost procedure that can be used to identify mutations that cause LS. We propose that this procedure be incorporated into clinical genetic analysis strategies and present a decision-support flow diagram for the diagnosis of LS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864635      PMCID: PMC2963912          DOI: 10.2353/jmoldx.2010.100039

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  23 in total

Review 1.  Hereditary colorectal cancer.

Authors:  Henry T Lynch; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

2.  Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome.

Authors:  Lucía Pérez-Carbonell; Cristina Alenda; Artemio Payá; Adela Castillejo; Víctor M Barberá; Carmen Guillén; Estefanía Rojas; Nuria Acame; Francisco J Gutiérrez-Aviñó; Antoni Castells; Xavier Llor; Montserrat Andreu; José-Luis Soto; Rodrigo Jover
Journal:  J Mol Diagn       Date:  2010-05-20       Impact factor: 5.568

3.  Germ-line msh6 mutations in colorectal cancer families.

Authors:  R D Kolodner; J D Tytell; J L Schmeits; M F Kane; R D Gupta; J Weger; S Wahlberg; E A Fox; D Peel; A Ziogas; J E Garber; S Syngal; H Anton-Culver; F P Li
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

4.  Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.

Authors:  Virgínia Piñol; Antoni Castells; Montserrat Andreu; Sergi Castellví-Bel; Cristina Alenda; Xavier Llor; Rosa M Xicola; Francisco Rodríguez-Moranta; Artemio Payá; Rodrigo Jover; Xavier Bessa
Journal:  JAMA       Date:  2005-04-27       Impact factor: 56.272

5.  Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer?

Authors:  Britta Halvarsson; Annika Lindblom; Eva Rambech; Kristina Lagerstedt; Mef Nilbert
Journal:  Virchows Arch       Date:  2003-12-02       Impact factor: 4.064

6.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

7.  BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.

Authors:  E Domingo; P Laiho; M Ollikainen; M Pinto; L Wang; A J French; J Westra; T Frebourg; E Espín; M Armengol; R Hamelin; H Yamamoto; R M W Hofstra; R Seruca; A Lindblom; P Peltomäki; S N Thibodeau; L A Aaltonen; S Schwartz
Journal:  J Med Genet       Date:  2004-09       Impact factor: 6.318

8.  Germline epimutation of MLH1 in individuals with multiple cancers.

Authors:  Catherine M Suter; David I K Martin; Robyn L Ward
Journal:  Nat Genet       Date:  2004-04-04       Impact factor: 38.330

9.  Frequent EpCam protein expression in human carcinomas.

Authors:  Philip Th Went; Alessandro Lugli; Sandra Meier; Marcel Bundi; Martina Mirlacher; Guido Sauter; Stephan Dirnhofer
Journal:  Hum Pathol       Date:  2004-01       Impact factor: 3.466

10.  Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families.

Authors:  Siobhan S Wahlberg; James Schmeits; George Thomas; Massimo Loda; Judy Garber; Sapna Syngal; Richard D Kolodner; Edward Fox
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

View more
  8 in total

Review 1.  EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients.

Authors:  Marjolijn J L Ligtenberg; Roland P Kuiper; Ad Geurts van Kessel; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

2.  Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion.

Authors:  Henry T Lynch; Douglas L Riegert-Johnson; Carrie Snyder; Jane F Lynch; Jill Hagenkord; C Richard Boland; Jennifer Rhees; Stephen N Thibodeau; Lisa A Boardman; Janine Davies; Roland P Kuiper; Nicoline Hoogerbrugge; Marjolijn J L Ligtenberg
Journal:  Am J Gastroenterol       Date:  2011-07-19       Impact factor: 10.864

3.  Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.

Authors:  Marlies J E Kempers; Roland P Kuiper; Charlotte W Ockeloen; Pierre O Chappuis; Pierre Hutter; Nils Rahner; Hans K Schackert; Verena Steinke; Elke Holinski-Feder; Monika Morak; Matthias Kloor; Reinhard Büttner; Eugene T P Verwiel; J Han van Krieken; Iris D Nagtegaal; Monique Goossens; Rachel S van der Post; Renée C Niessen; Rolf H Sijmons; Irma Kluijt; Frans B L Hogervorst; Edward M Leter; Johan J P Gille; Cora M Aalfs; Egbert J W Redeker; Frederik J Hes; Carli M J Tops; Bernadette P M van Nesselrooij; Marielle E van Gijn; Encarna B Gómez García; Diana M Eccles; David J Bunyan; Sapna Syngal; Elena M Stoffel; Julie O Culver; Melanie R Palomares; Tracy Graham; Lea Velsher; Janos Papp; Edith Oláh; Tsun L Chan; Suet Y Leung; Ad Geurts van Kessel; Lambertus A L M Kiemeney; Nicoline Hoogerbrugge; Marjolijn J L Ligtenberg
Journal:  Lancet Oncol       Date:  2010-12-08       Impact factor: 41.316

4.  History and pathogenesis of lynch syndrome.

Authors:  Brian J Bansidhar; Jennifer Silinsky
Journal:  Clin Colon Rectal Surg       Date:  2012-06

5.  EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndrome.

Authors:  Sagar J Pathak; James L Mueller; Kevin Okamoto; Barun Das; Jozef Hertecant; Lynn Greenhalgh; Trevor Cole; Vered Pinsk; Baruch Yerushalmi; Odul E Gurkan; Michael Yourshaw; Erick Hernandez; Sandy Oesterreicher; Sandhia Naik; Ian R Sanderson; Irene Axelsson; Daniel Agardh; C Richard Boland; Martin G Martin; Christopher D Putnam; Mamata Sivagnanam
Journal:  Hum Mutat       Date:  2018-11-29       Impact factor: 4.878

Review 6.  Gender-Specific Aspects of Lynch Syndrome and Familial Adenomatous Polyposis.

Authors:  Ralph Schneider; Claudia Schneider; Christian Jakobeit; Alois Fürst; Gabriela Möslein
Journal:  Viszeralmedizin       Date:  2014-04

7.  Germline deletions in the EPCAM gene as a cause of Lynch syndrome - literature review.

Authors:  Katarzyna Tutlewska; Jan Lubinski; Grzegorz Kurzawski
Journal:  Hered Cancer Clin Pract       Date:  2013-08-12       Impact factor: 2.857

8.  Whole-Genome Profiles of Malay Colorectal Cancer Patients with Intact MMR Proteins.

Authors:  Wan Khairunnisa Wan Juhari; Khairul Bariah Ahmad Amin Noordin; Andee Dzulkarnaen Zakaria; Wan Faiziah Wan Abdul Rahman; Wan Muhamad Mokhzani Wan Muhamad Mokhter; Muhammad Radzi Abu Hassan; Ahmad Shanwani Mohammed Sidek; Bin Alwi Zilfalil
Journal:  Genes (Basel)       Date:  2021-09-20       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.